Back to search

University of Patras

Η δράση του υαλουρονικού, σε μοριακό και κυτταρικό επίπεδο, σε καρκινικά κύτταρα μαστού με διαφοροποιημένη έκφραση οιστρογονοϋποδοχέων

Abstract

dc:description

Breast cancer is a heterogeneous and complicated disease. The estrogen receptors (ERs), that are used to categorize the types of the disease and the extracellular matrix (ECM) biomolecules, whose expression patterns are modulated during the disease, play pivotal role during its progression. Hyaluronan (HA) is one of the major ECM macromolecules. Its high expression levels have been correlated with poor prognosis and malignant phenotype in various cancer types, including breast cancer. Depending on its molecular size, HA exhibits different physicochemical and biological properties and it is able to regulate the cellular responses and behavior in a different mode. In breast cancer, HA of different molecular sizes promotes or attenuates signaling pathways that control cancer progression. During the first stage of the present doctoral thesis, HA of different molecular sizes was isolated. Three of them (<10, 30 and 200 kDa) were evaluated on their effects on breast cancer cells of different ER status. For this purpose, low metastatic, ERα+ cells breast cancer cells (MCF-7) and highly metastatic ERα-/β+ breast cancer cells (MDA-MB-231) were used. This study demonstrates by using scanning electron microscopy (SEM) that the HA affects cellular morphology. In particular, 200 kDa ΗΑ promotes an epithelial- like phenotype. This observation is supported by modulations on the expression patterns of epithelial-to-mesenchymal transition (EMT) markers, of the mesenchymal type MDA-MB-231 cells. Reduction of the expression levels of the mesenchymal markers snail2/slug, fibronectin and vimentin was observed. On the contrary, the expression levels of the epithelial marker E-cadherin were increased. Furthermore, the expression levels of important molecules, such as CD44 (HA receptor), HA synthase 2 (HAS2) and several metalloproteinases (MMPs), that are correlated with cellular aggressiveness and invasiveness, were reduced. The modulations above led to modulations of the cellular functional properties, reducing breast cancer cells’ proliferation and invasion. This effect possibly occurs partly due to the competition between the exogenously added HA fragments with the endogenous HA, to bind to CD44 as well as to attenuate the activation of proteins such as ERK1/2 and Akt. These proteins constitute key regulators of cellular behavior. Moreover, the molecular sizes of HA that were studied, reduced cellular migration by increasing cellular adhesion, and the expression levels of syndecan 4.The transfected cells shERβ MDA-MB-231, which have been developed in the lab, express significantly lower levels of ERβ. As a result, they are characterized by reduced aggressiveness in comparison to MDA-MB-231 cells and their morphology as well as the expression patterns of several key molecules have been changed. The present study demonstrates that HA is able to trigger phenotypical changes and regulate the behavior of these cells. In particular, 200 kDa HA reduces the proliferation and the invasive capacity of the shERβ MDA-MB-231 cells. Moreover, 200 kDa HA modulates the expression profile of key regulators of the cellular behavior, such as CD44, HAS2 and MMP7. In addition, it promotes the epithelial phenotype of these cells, upregulating the expression levels of E-cadherin and downregulating the expression levels of the mesenchymal marker snail2/slug. However, changes of the migratory capacity of the cells after the HA treatment were not observed, underlining the importance of ER status on breast cancer cells’ responses and behavior. In conclusion, the data of the present doctoral thesis clearly demonstrate that the HA effects on breast cancer cells depend on its molecular size as well as the ER status of the cells. Furthermore, they indicate the anti-cancer properties of 200 kDa HA in the breast cancer cell lines that were studied. Therefore, 200 kDa HA could be a useful tool in the development of therapeutic strategies against aggressive types of breast cancer.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tavianatou, Anastasia-Gerasimoula
  • Ταβιανάτου, Αναστασία-Γερασιμούλα

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/46495

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tavianatou, Anastasia-Gerasimoula; Ταβιανάτου, Αναστασία-Γερασιμούλα. Η δράση του υαλουρονικού, σε μοριακό και κυτταρικό επίπεδο, σε καρκινικά κύτταρα μαστού με διαφοροποιημένη έκφραση οιστρογονοϋποδοχέων. University of Patras, 2019. http://hdl.handle.net/10442/hedi/46495